FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
Bellerophon Therapeutics (NASDAQ: BLPH) reported Q1 EPS of ($0.54), $0.11 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
... More
